Enhancement by muramyl peptides of the protective response of interferon-α/β against encephalomyocarditis virus infection

This publication has 24 references indexed in Scilit:

• Synergistic Effects Between Recombinant Interleukin-2 and the Synthetic Immunomodulator Murabutide: Selective Enhancement of Cytokine Release and Potentiation of Antitumor Activity
  Journal of Interferon & Cytokine Research, 1996
• Immunopharmacological activities and clinical development of muramyl peptides with particular emphasis on murabutide
  International Journal of Immunopharmacology, 1995
• Role of Interferon in Lethality and Lymphoid Atrophy Induced by Coxsackievirus B3 Infection of Mice
  Viral Immunology, 1991
• In vitro regulation by muramyl dipeptide of interferon production from peripheral blood mononuclear cells of healthy volunteers
  International Journal of Immunopharmacology, 1988
• Enhancement of host resistance against virus infections by MTP-PE, a synthetic lipophilic muramyl peptide — I. Increased survival in mice and guinea pigs after single drug administration prior to infection, and the effect of MTP-PE on interferon levels in sera and lungs
  International Journal of Immunopharmacology, 1986
• Purification of Highly Radioactive Mouse Interferon Produced by Ehrlich Ascites Tumour Cells Induced by Sendai Virus
  Journal of General Virology, 1983
• Effect of sodium butyrate on the antiviral and anticellular action of interferon in normal and MSV‐transformed cells
  International Journal of Cancer, 1979
• Human Fibroblast Interferon for Clinical Trials: Pharmacokinetics and Tolerability in Experimental Animals and Humans
  Antimicrobial Agents and Chemotherapy, 1979
• Isolation of murine sarcoma virus‐transormed mouse cells which are negative for leukemia virus from agar suspension cultures
  International Journal of Cancer, 1970
• Decreased interferon sensitivity and production in cells transformed by sv40 and other oncogenic agents
  International Journal of Cancer, 1969